Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A44610 | 27986173 | Semin Ultrasound CT MR | Liver Function Assessment by Magnetic Resonance Imaging. | 2016 | Details |
| A44611 | 27981609 | Hepatology | The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis. | 2017 | Details |
| A44612 | 27981604 | Hepatology | Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice. | 2017 | Details |
| A44613 | 27966442 | Neth J Med | A black umbilicus in a patient with a decompensated liver cirrhosis. | 2016 | Details |
| A44614 | 27958883 | Antioxid Redox Signal | Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1. | 2017 | Details |
| A44615 | 27942586 | JCI Insight | IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans. | 2016 | Details |
| A44616 | 27936906 | Child Obes | Metabolic Consequences of Obstructive Sleep Apnea in Adolescents with Obesity: A Systematic Literature Review and Meta-Analysis. | 2016 | Details |
| A44617 | 27935207 | Liver Transpl | Living donor liver transplantation with a left trisegmental graft from a donor with anomalous branching of the portal vein. | 2017 | Details |
| A44618 | 27932209 | J Hepatol | Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver. | 2016 | Details |
| A44619 | 27924102 | Am J Gastroenterol | The Heart Age Is Increased in Patients With Nonalcoholic Fatty Liver Disease and Correlates With Fibrosis and Hepatocyte Ballooning. | 2016 | Details |
| A44620 | 27919110 | Z Gastroenterol | [Prime time for medical therapy in NASH?] | 2016 | Details |
| A44621 | 27918820 | JAMA Intern Med | Importance of Determining Maximal Heart Rate for Providing a Standardized Training Stimulus-Reply. | 2016 | Details |
| A44622 | 27918814 | JAMA Intern Med | Importance of Determining Maximal Heart Rate for Providing a Standardized Training Stimulus. | 2016 | Details |
| A44623 | 27918207 | Can J Physiol Pharmacol | Gemigliptin ameliorates Western-diet-induced metabolic syndrome in mice. | 2016 | Details |
| A44624 | 27917074 | Gastroenterol Hepatol (N Y) | Medical Management of Metabolic Complications of Liver Transplant Recipients. | 2016 | Details |
| A44625 | 27914812 | Biochem Biophys Res Commun | Protective effects of gomisin N against hepatic steatosis through AMPK activation. | 2016 | Details |
| A44626 | 27914695 | Nutr Metab Cardiovasc Dis | Reply from the authors to "Comments on 'Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk'". | 2016 | Details |
| A44627 | 27897271 | Sci Rep | Corrigendum: SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy. | 2016 | Details |
| A44628 | 27890867 | Gut Liver | Obesity-Related Digestive Diseases and Their Pathophysiology. | 2017 | Details |
| A44629 | 27880988 | Hepatology | Pioglitazone for advanced fibrosis in nonalcoholic steatohepatitis: New evidence, new challenges. | 2017 | Details |
| A44630 | 27865560 | Metabolism | Reply to "statins and non-alcoholic steatohepatitis". | 2016 | Details |
| A44631 | 27862126 | Hepatology | The increasing burden of NAFLD fibrosis in the general population: Time to bridge the gap between hepatologists and primary care. | 2017 | Details |
| A44632 | 27861140 | J Pediatr Endocrinol Metab | Non-alcoholic fatty liver disease in children and adolescents. | 2016 | Details |
| A44633 | 27859430 | Hepatology | High prevalence of nonalcoholic fatty liver disease in the middle east: Lifestyle and dietary habits. | 2017 | Details |
| A44634 | 27856769 | J Mol Cell Biol | New insights into complex diseases. | 2016 | Details |
| A44635 | 27856218 | J Hepatol | Comment to: "EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease". | 2016 | Details |
| A44636 | 27856217 | J Hepatol | Response to: Comment to "EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease". | 2016 | Details |
| A44637 | 27856200 | Dig Liver Dis | Good response to the primary course and booster dose of hepatitis B vaccine in children with non-alcoholic fatty liver disease. | 2016 | Details |
| A44638 | 27848963 | Nat Rev Gastroenterol Hepatol | Steatohepatitis: PARP inhibition protective against alcoholic steatohepatitis and NASH. | 2016 | Details |
| A44639 | 27842716 | Metabolism | Response letter: Statins and non-alcoholic steatohepatitis. | 2016 | Details |
| A44640 | 27838198 | J Cardiothorac Vasc Anesth | Serotonin Syndrome Resulting From Acute Decompensation of Nonalcoholic Steatohepatitis Cirrhosis in a Patient Chronically Treated With Citalopram and Tramadol. | 2016 | Details |
| A44641 | 27836113 | Metabolism | Statins and non-alcoholic steatohepatitis. | 2016 | Details |
| A44642 | 27834389 | Nat Rev Endocrinol | NASH: Understanding how steatosis progresses to NASH. | 2016 | Details |
| A44643 | 27826560 | Hepatobiliary Surg Nutr | Inflammation, mitochondrial metabolism and nutrition: the multi-faceted progression of non-alcoholic fatty liver disease to hepatocellular carcinoma. | 2016 | Details |
| A44644 | 27826559 | Hepatobiliary Surg Nutr | Immune surveillance of liver cancer in non-alcoholic fatty liver disease: excess lipids cause CD4 T-cells loss and promote hepatocellular carcinoma development. | 2016 | Details |
| A44645 | 27823767 | J Pediatr | Reversal of Nonalcoholic Steatohepatitis in Adolescents after Metabolic Surgery. | 2016 | Details |
| A44646 | 27822554 | mSystems | Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism. | 2016 | Details |
| A44647 | 27822267 | Hepat Mon | Comments on "Rural Residency has a Protective Effect and Marriage is a Risk Factor for NAFLD". | 2016 | Details |
| A44649 | 27807356 | Nat Rev Drug Discov | Nonalcoholic steatohepatitis (NASH) drugs market. | 2016 | Details |
| A44650 | 27807313 | Hong Kong Med J | Effect of combined use of Fructus Schisandrae and statin on high-fat-diet-induced metabolic syndrome in rats. | 2016 | Details |
| A44651 | 27516341 | Nat Rev Endocrinol | Endoplasmic reticulum proteostasis in hepatic steatosis. | 2016 | Details |
| A44652 | 27792216 | Minerva Endocrinol | Endocrine and metabolic disorders interplaying with non-alcoholic fatty liver disease. | 2016 | Details |
| A44653 | 27788728 | Zhonghua Gan Zang Bing Za Zhi | [Related factors for heart rate recovery after treadmill exercise testing in patients with nonalcoholic fatty liver disease]. | 2016 | Details |
| A44654 | 27788710 | Zhonghua Gan Zang Bing Za Zhi | [Effect of liraglutide on expression of insulin-like growth factor 2-mRNA binding protein 3 in liver in rats with non-alcoholic fatty liver disease]. | 2016 | Details |
| A44655 | 27664470 | Am J Pathol | REV-ERBα Activates C/EBP Homologous Protein to Control Small Heterodimer Partner-Mediated Oscillation of Alcoholic Fatty Liver. | 2016 | Details |
| A44656 | 27592097 | J Pediatr | Autism Spectrum Disorders and Metabolic Complications of Obesity. | 2016 | Details |
| A44657 | 27783862 | Compr Physiol | Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation. | 2016 | Details |
| A44658 | 27780762 | Clin Gastroenterol Hepatol | Differential Expression of miRNAs in Nontumor Liver Tissue of Patients With Hepatocellular Cancer Caused by Nonalcoholic Steatohepatitis Cirrhosis. | 2016 | Details |
| A44659 | 27780656 | J Formos Med Assoc | Uncovered issues in the association between uric acid and nonalcoholic fatty liver disease. | 2016 | Details |
| A44660 | 31041073 | Clin Liver Dis (Hoboken) | Natural history of nonalcoholic steatohepatitis/nonalcoholic fatty liver disease-hepatocellular carcinoma: Magnitude of the problem from a hepatology clinic perspective. | 2016 | Details |
| A44661 | 27628621 | Hepatology | Workforce in hepatology: Update and a critical need for more information. | 2016 | Details |
| A44662 | 27567691 | Clin Gastroenterol Hepatol | Perilipin Staining Distinguishes Between Steatosis and Nonalcoholic Steatohepatitis in Adults and Children. | 2016 | Details |
| A44663 | 27486047 | Dig Liver Dis | Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy. | 2016 | Details |
| A44664 | 27769733 | J Hepatol | Reply to: "Procoagulant imbalance in patients with non-alcoholic fatty liver disease". | 2016 | Details |
| A44665 | 27769731 | J Hepatol | Procoagulant imbalance in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A44666 | 27639263 | Hepatology | Modeling fatty liver disease in animals: Is there an optimal approach, and is the effort worthwhile? | 2016 | Details |
| A44667 | 27629157 | Hepatology | Hepatocellular carcinoma in nonalcoholic fatty liver disease: A link between oxidative stress and T-cell suppression. | 2016 | Details |
| A44668 | 27480050 | Hepatology | Nonalcoholic fatty liver disease and metabolic syndrome: Shared genetic basis of pathogenesis. | 2016 | Details |
| A44669 | 27198998 | World J Surg | Association Between Cholecystectomy and Nonalcoholic Fatty Liver Disease: A Meta-analysis: Reply. | 2016 | Details |
| A44670 | 27117944 | Hepatology | Clinical outcomes after coronary angiography in nonalcoholic fatty liver disease. | 2016 | Details |
| A44671 | 26940581 | World J Surg | Association Between Cholecystectomy and Nonalcoholic Fatty Liver Disease: A Meta-analysis. | 2016 | Details |
| A44672 | 27707773 | J Mol Endocrinol | Additive effects of dexamethasone and palmitate on hepatic lipid accumulation and secretion. | 2016 | Details |
| A44673 | 27699898 | J Intern Med | Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids. | 2016 | Details |
| A44674 | 27419664 | Clin Exp Pharmacol Physiol | 6-Methylsulfinylhexyl isothiocyanate prevents high-fat diet-induced fatty liver but fails to attenuate hepatic iron accumulation in mice. | 2016 | Details |
| A44675 | 27754600 | J Diabetes | A case of ruptured hepatocellular carcinoma (HCC) in resolving non-alcoholic steatohepatitis associated with type 2 diabetes: Is early detection of diabetes-related HCC feasible? | 2016 | Details |
| A44676 | 27752939 | Mol Biol Rep | Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults. | 2016 | Details |
| A44677 | 27751514 | Med Clin (Barc) | Non-alcoholic fatty liver disease and diabetes. | 2016 | Details |
| A44678 | 27435327 | Dig Dis Sci | Targeting Hepatic Fibrosis in Autoimmune Hepatitis. | 2016 | Details |
| A44679 | 27155555 | Clin Gastroenterol Hepatol | Association Between Severity of Obstructive Sleep Apnea and Blood Markers of Liver Injury. | 2016 | Details |
| A44680 | 27749611 | J Pediatr Gastroenterol Nutr | The Use of Probiotics in Pediatric Nonalcoholic Fatty Liver Disease: Teachable Moment or Missed Opportunity? | 2017 | Details |
| A44681 | 27746822 | Evid Based Complement Alternat Med | Effects of Hot Water Extracts from Polygonum multiflorum on Ovariectomy Induced Osteopenia in Mice. | 2016 | Details |
| A44682 | 27743989 | J Hepatol | The association between sarcopenia and non-alcoholic fatty liver disease. | 2016 | Details |
| A44683 | 27743988 | J Hepatol | Reply to: "The association between sarcopenia and non-alcoholic fatty liver disease". | 2016 | Details |
| A44684 | 27742132 | J Hepatol | Fatty liver in adolescents: Mechanisms, clinical features and therapy. | 2016 | Details |
| A44685 | 27740531 | Ann Hepatol |  Estimated time from clinical presentation to the development of cirrhosis in non-cirrhotic adult patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A44686 | 27738886 | Endocrine | Circulating periostin in patients with nonalcoholic fatty liver disease. | 2016 | Details |
| A44687 | 27737511 | Hepatology | Nonalcoholic fatty liver disease: Biomarkers support decisions around pharmacological intervention. | 2016 | Details |
| A44688 | 27734622 | Intern Med J | Is it possible to distinguish between glycogenic hepatopathy and non-alcoholic fatty liver disease without liver biopsy? | 2016 | Details |
| A44689 | 27734248 | Dig Dis Sci | FXR Agonists: From Bench to Bedside, a Guide for Clinicians. | 2016 | Details |
| A44690 | 27732084 | Endocrinology | RABL2 Is Required for Hepatic Fatty Acid Homeostasis and Its Dysfunction Leads to Steatosis and a Diabetes-Like State. | 2016 | Details |
| A44691 | 27729311 | BMJ | Ruling out fibrosis in non-alcoholic fatty liver disease. | 2016 | Details |
| A44692 | 27722155 | Gastrointest Tumors | Prevention of Hepatocellular Carcinoma. | 2016 | Details |
| A44693 | 27718255 | Hepatology | Nonalcoholic steatohepatitis and the intestinal microbiota. | 2016 | Details |
| A44694 | 27716754 | Rev Gastroenterol Peru | [Non alcoholic fatty liver: a growing epidemic]. | 2017 | Details |
| A44695 | 27712983 | Clin Gastroenterol Hepatol | Acculturation and Nonalcoholic Fatty Liver Disease Risk Among Hispanics of Mexican Origin: Findings From the National Health and Nutrition Examination Survey. | 2016 | Details |
| A44696 | 27712981 | Clin Gastroenterol Hepatol | Weight Loss Decreases Magnetic Resonance Elastography Estimated Liver Stiffness in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A44697 | 27709857 | J Korean Med Sci | Distribution of Diseases Causing Liver Function Test Abnormality in Children and Natural Recovery Time of the Abnormal Liver Function. | 2016 | Details |
| A44698 | 27698966 | Middle East J Dig Dis | New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article. | 2016 | Details |
| A44699 | 27689184 | Ultrasound Int Open | Dynamic Change of Focal Fatty Sparing in Non-Alcoholic Fatty Liver Disease after Treatment with Sitagliptin. | 2016 | Details |
| A44700 | 30191046 | Hepat Oncol | Dysregulated fatty acid metabolism in hepatocellular carcinoma. | 2017 | Details |
| A44701 | 27683821 | J Infect Dis | Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C. | 2016 | Details |
| A44702 | 27679730 | J Ultrason | Is a fatty pancreas a banal lesion? | 2016 | Details |
| A44703 | 27679492 | Gut | Non-alcoholic fatty liver disease as driving force in coronary heart disease? | 2016 | Details |
| A44704 | 27678349 | World J Gastroenterol | Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease. | 2016 | Details |
| A44705 | 27670349 | Obes Res Clin Pract | The effect of high intensity statin use on liver density: A post hoc analysis of the coronary artery calcification treatment with zocor [CATZ] study. | 2016 | Details |
| A44706 | 27658392 | Diabetes | Ubiquitin Ligase COP1 Controls Hepatic Fat Metabolism by Targeting ATGL for Degradation. | 2016 | Details |
| A44707 | 27650699 | Hepatology | Nonalcoholic steatohepatitis in nonobese patients: Not so different after all. | 2016 | Details |
| A44708 | 27639247 | Hepatology | Serum biomarkers for nonalcoholic fatty liver disease: Are we there yet? | 2016 | Details |
| A44709 | 27639178 | Hepatology | Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood. | 2016 | Details |
| A44710 | 27635189 | Oxid Med Cell Longev | Liver Cholesterol Overload Aggravates Obstructive Cholestasis by Inducing Oxidative Stress and Premature Death in Mice. | 2016 | Details |